Intermediate hepatocellular carcinoma: current treatments and future perspectives von Dufour, J-F, Bargellini, I, De Maria, N, De Simone, P, Goulis, I, Marinho, R T

Volltext

Severe gastrointestinal cryptosporidiosis three years after multi-visceral transplantation von Tsakona, A, Syrnioti, A, Goulis, I, Hytiroglou, P

Volltext

Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation von Cholongitas, E., Vasiliadis, T., Antoniadis, N., Goulis, I., Papanikolaou, V., Akriviadis, E.

Volltext

Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation von Cholongitas, E., Goulis, I., Antoniadis, N., Fouzas, I., Imvrios, G., Giakoustidis, D., Giouleme, O., Papanikolaou, V., Akriviadis, E., Vasiliadis, T.

Volltext

Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease von Sinakos, E, Panas, P, Fragkou, N, Antoniadis, N, Katsanos, G, Tsakni, E, Oikonomou, T, Notopoulos, A, Tsoulfas, G, Goulis, I, Akriviadis, E

Volltext

Trough Levels of Everolimus Are Associated With Recurrence Rates of Hepatocellular Carcinoma After Liver Transplantation von Cholongitas, E., Antoniadis, N., Goulis, I., Theocharidou, E., Ιmvrios, G., Giouleme, O., Filis, D., Mouloudi, E., Akriviadis, E., Fouzas, I.

Volltext

Telbivudine is associated with improvement of renal function in patients transplanted for HBV liver disease von Cholongitas, E., Vasiliadis, T., Goulis, I., Fouzas, I., Antoniadis, N., Papanikolaou, V., Akriviadis, E.

Volltext

Comparison of Creatinine and Cystatin C Based Glomerular Filtration Rate Formulae with 51Chromium-EDTA clearance in Patients with Decompensated Cirrhosis von Cholongitas, E, Goulis, I, Ioannidou, M, Soulaidopoulos, S, Chalevas, P, Akriviadis, E

Volltext

Urine Albumin-To-Creatinine Ratio is Associated with the Severity of Liver Disease, Renal Function and Survival in Patients with Decompensated Cirrhosis von Cholongitas, E, Goulis, I, Ioannidou, M, Soulaidopoulos, S, Chalevas, P, Akriviadis, E

Volltext

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference von Papatheodoridis, G., Thomas, H. C., Golna, C., Bernardi, M., Carballo, M., Cornberg, M., Dalekos, G., Degertekin, B., Dourakis, S., Flisiak, R., Goldberg, D., Gore, C., Goulis, I., Hadziyannis, S., Kalamitsis, G., Kanavos, P., Kautz, A., Koskinas, I., Leite, B. R., Malliori, M., Manolakopoulos, S., Matičič, M., Papaevangelou, V., Pirona, A., Prati, D., Raptopoulou - Gigi, M., Reic, T., Robaeys, G., Schatz, E., Souliotis, K., Tountas, Y., Wiktor, S., Wilson, D., Yfantopoulos, J., Hatzakis, A.

Volltext

Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosis von Oikonomou, T., Cholongitas, E., Gioula, G., Minti, F., Melidou, A., Protonotariou, E., Akriviadis, E., Goulis

Volltext

The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference von Hatzakis, A., Van Damme, P., Alcorn, K., Gore, C., Benazzouz, M., Berkane, S., Buti, M., Carballo, M., Cortes Martins, H., Deuffic-Burban, S., Dominguez, A., Donoghoe, M., Elzouki, A-N., Ben-Alaya Bouafif, N., Esmat, G., Esteban, R., Fabri, M., Fenton, K., Goldberg, D., Goulis, I., Hadjichristodoulou, T., Hatzigeorgiou, T., Hamouda, O., Hasurdjiev, S., Hughes, S., Kautz, A., Malik, M., Manolakopoulos, S., Matičič, M., Papatheodoridis, G., Peck, R., Peterle, A., Potamitis, G., Prati, D., Roudot-Thoraval, F., Reic, T., Sharara, A., Shennak, M., Shiha, G., Shouval, D., Sočan, M., Thomas, H., Thursz, M., Tosti, M., Trépo, C., Vince, A., Vounou, E., Wiessing, L., Manns, M.

Volltext

P392 ANTI-SLA/LP ALONE OR IN COMBINATION WITH ANTI-Ro52 AND FINE SPECIFICITY OF ANTI-Ro52 ANTIBODIES IN PATIENTS WITH AUTOIMMUNE HEPATITIS von Zachou, K, Gabeta, S, Gatselis, N.K, Oikonomou, K, Goulis, I, Manoussakis, M.N, Renaudineau, Y, Bogdanos, D.P, Dalekos, G.N

Volltext

P401 DISEASE PROGRESSION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS UNDER LONG-TERM TREATMENT WITH URSODEOXYCHOLIC ACID – A HISTOLOGY-BASED ANALYSIS von Sinakos, E, Vasiliadis, T, Goulis, I, Papalavrentios, L, Perlepe, N, Patsiaoura, K, Hytiroglou, P, Akriviadis, E

Volltext

Restrictions for reimbursement of interferon-free direct-acting antiviral therapies for HCV infection in Europe von Marshall, A.D, Nielsen, S, Cunningham, E.B, Aghemo, A, Alho, H, Backmund, M, Bruggmann, P, Dalgard, O, Flisiak, R, Foster, G, Gheorghe, L, Goldberg, D, Goulis, I, Hickman, M, Hoffmann, P, Jancorienė, L, Jarčuška, P, Kåberg, M, Makara, M, Maimets, M, Marinho, R, Matičič, M, Norris, S, Olafsson, S, Øvrehus, A, Pawlotsky, J.-M, Pocock, J, Robaeys, G, Roncero, C, Simonova, M, Sperl, J, Tait, M, Tolmane, I, Tomaselli, S, van der Valk, M, Vince, A, Dore, G.J, Lazarus, J.V, Grebely, J

Volltext

Distribution of Hepatitis C Virus genotypes in northern Greece in the last decade: descriptive analysis and clinical correlations von Gioula, G, Sinakos, E, Gigi, E, Goulis, I, Vasiliadis, T, Minti, F, Akriviadis, E

Volltext

P0079 : Nucleos(t)ide analogue prophylaxis after hepatitis B immunoglobulin withdrawal is safe and effective against hepatitis B and D recurrence after liver transplantation von Cholongitas, E, Vasiliadis, T, Goulis, I, Antoniadis, N, Chalevas, P, Fouzas, I, Giakoustidis, D, Imvrios, G, Giouleme, O, Papanikolaou, V, Akriviadis, E

Volltext

Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study von TSOCHATZIS, E., MANOLAKOPOULOS, S., PAPATHEODORIDIS, G. V., HADZIYANNIS, E., TRIANTOS, C., ZISIMOPOULOS, K., GOULIS, I., TZOURMAKLIOTIS, D., AKRIVIADIS, E., MANESIS, E. K., ARCHIMANDRITIS, A. J.

Volltext

511 HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEA... von Goulis, I, Akriviadis, E, Karatapanis, S, Deutsch, M, Dalekos, G, Raptopoulou-Gigi, M, Mimidis, K, Germanidis, G, Triantos, C, Drakoulis, C, Chounta, A, Tsoplou, F, Zintzaras, E, Bakalos, G, Papatheodoridis, G

Volltext

714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT von Goulis, I, Akriviadis, E, Karatapanis, S, Deutsch, M, Dalekos, G, Raptopoulou-Gigi, M, Drakoulis, C, Bakalos, G, Papatheodoridis, G

Volltext